Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Shell and core dosage form approaching zero-order drug release

Shell and core dosage form approaching zero-order drug release

US Patent 8329215 · Granted Dec 11, 2012

Estimated economic value: $1,355,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Topical naloxone compositions and methods for using the same2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2024
5-hydroxytryptophan gastroretentive dosage forms2023
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods 2022
Pharmaceutical formulations2022
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modifi2021
Methods and compositions for transdermal delivery of a non-sedative amount of de2021
Methods and compositions for treating attention deficit hyperactivity disorder, 2020
Dexmedetomidine transdermal delivery devices and methods for using the same2020
Topical sphingosine-1-phosphate receptor agonist formulations and methods of usi2020